3.4(top 5%)
Impact Factor
3.7(top 5%)
extended IF
55(top 7%)
H-Index
2.3K
authors
1.9K
papers
17.9K
citations
2.9K
citing journals
15.4K
citing authors
Selected Period:
-
Impact Factor of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy based on the number of citations over 2-year window
The graph shows the changes in the impact factor of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy and its the corresponding percentile for the sake of comparison with the entire literature. Impact Factor is the most common scientometric index, which is defined by the number of citations of papers in two preceding years divided by the number of papers published in those years.

How Influential is Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy?

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is the 279th out of 1,169 Pharmacology journals. This Journal is the 1679th out of 8,993 Life Sciences journals. This means the journal is among the top 19% in the science branch of Life Sciences. This Journal is the 1896th out of 14,350 Health Sciences journals. This means the journal is among the top 14% in the science branch of Health Sciences.